Rocky mountain Spotted Fever Misdiagnosed as an Acute Drug Reaction: Diagnostic Clues and Evaluation Recommendations

Rocky Mountain Spotted Fever

Authors

  • Atieh Jibbe, M.D. University of Kansas Division of Dermatology
  • Brett C. Neill, M.D. University of Kansas Medical Center
  • Stan N. Tolkachjov, M.D. Epiphany Dermatology, Dallas, TX

DOI:

https://doi.org/10.17161/kjm.vol1415223

Keywords:

tickborne illness, rocky mountain spotted fever, drug rash

Metrics

File downloads
413
Jul 10 '21Jul 13 '21Jul 16 '21Jul 19 '21Jul 22 '21Jul 25 '21Jul 28 '21Jul 31 '21Aug 01 '21Aug 04 '21Aug 07 '214.0
| |

Downloads

Published

2021-07-09

Issue

Vol. 14 No. 2 (2021): May - Aug.

Section

Images

License

Copyright (c) 2021 Atieh Jibbe, M.D., Brett C. Neill, M.D., Stan N. Tolkachjov, M.D.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Jibbe, A., Neill, B., & Tolkachjov, S. (2021). Rocky mountain Spotted Fever Misdiagnosed as an Acute Drug Reaction: Diagnostic Clues and Evaluation Recommendations: Rocky Mountain Spotted Fever. Kansas Journal of Medicine, 14(2), 186-187. https://doi.org/10.17161/kjm.vol1415223